b
r
c
tmca
acid
ester
amid
privileg
structur
scaffold
drug
discoveri
wide
distribut
natur
product
consequ
produc
divers
therapeut
relev
pharmacolog
function
owe
potenti
tmca
ester
amid
analogu
therapeut
agent
research
chemic
synthes
modif
carri
druglik
candid
broad
rang
medicin
properti
antitumor
antivir
cn
central
nervou
system
agent
antimicrobi
antiinflammatori
hematolog
agent
long
time
time
sar
structureact
relationship
studi
draw
greater
attent
among
medicin
chemist
mani
lead
compound
deriv
variou
diseas
target
howev
urgent
need
medicin
chemist
exploit
precursor
develop
chemic
entiti
promis
bioactiv
druggabl
review
concis
summar
synthesi
biolog
activ
tmca
ester
amid
analogu
also
comprehens
reveal
relationship
signific
biolog
activ
along
sar
studi
tmca
cinnam
acid
substitut
multimethoxi
group
fig
consid
activ
metabolit
root
polygala
tenuifolia
wild
polygalacea
use
tradit
medicin
china
treat
insomnia
headach
epilepsi
tmca
report
show
anticonvuls
sed
activ
former
studi
mechan
research
reveal
act
gabaabz
receptor
agonist
antiseizur
insomnia
therapi
appeal
structur
scaffold
pharmacolog
import
tmca
encourag
research
synthes
driv
novel
drug
candid
tmca
deriv
attract
great
attent
interest
research
field
medicin
chemistri
tmca
act
precursor
construct
larg
number
structur
framework
divers
applic
carboxyl
group
tmca
frequent
concern
group
modif
addit
ester
amid
deriv
import
analogu
report
review
substitut
point
bond
methoxi
group
also
briefli
mention
articl
modif
framework
lead
broaden
activ
continuum
tmca
analogu
pharmacolog
research
review
focu
properti
tmca
ester
amid
antitumor
antivir
cn
agnet
antimicrobi
antiinflammatori
hematolog
agent
summar
advanc
natur
product
tmca
analogu
synthet
deriv
synthet
deriv
investig
tmca
core
nucleu
activ
substitu
review
use
tmca
substitu
analogu
compar
potent
compound
accord
sar
point
view
review
dedic
accomplish
urgent
need
compil
summar
natur
product
biolog
activ
sar
could
help
research
design
new
potenti
activ
tmca
analogu
develop
societi
health
problem
arous
attent
worldwid
side
effect
multidrugresist
exist
clinic
util
modern
drug
forc
research
set
sight
natur
product
seek
precursor
safeti
effici
tcm
tradit
chines
medicin
cluster
timehonor
herb
medicin
attract
much
attent
develop
new
drug
research
group
made
unremit
effort
seek
promis
lead
compound
tcm
tmca
p
tenuifolia
also
aasaron
acoru
gramineu
salvian
acid
salvia
miltiorrhiza
vanillyl
alcohol
gastrodia
elata
absorb
investig
combin
tradit
chines
medicin
chemistri
ctcmc
main
drug
design
strategi
fig
mean
integr
activ
constitu
base
tcm
theori
accordint
strategi
ctcmc
develop
potenti
lead
compound
includ
dbz
tanshinol
borneol
ester
analogu
tmcaaasaronol
ester
believ
strategi
benefit
innov
new
drug
natur
product
moreov
consid
strategi
help
decreas
cost
screen
test
compound
blind
exist
structur
modif
natur
product
biolog
activ
natur
tmca
ester
amid
deriv
tmca
ester
amid
isol
natur
product
tmca
ester
wide
distribut
sever
type
medicin
plant
genu
polygala
contain
spiec
p
tenuifolia
richest
resourc
tmca
ester
addit
tmca
ester
also
exist
genu
erythroxylum
rauwolfia
disinapoyl
sucros
activ
oligosaccharid
acyl
compon
obtain
root
p
tenuifolia
record
standard
qualiti
control
p
tenuifolia
use
hplc
high
perform
liquid
chromatographi
determin
method
accord
edit
chines
pharmacopoeia
fig
tmca
demonstr
metabolit
latter
show
antidepress
activ
mediat
via
inhibit
mao
monoamin
oxidas
maob
activ
reduc
plasma
cortisol
mda
level
increas
sod
superoxid
dismutas
activ
tenuifolisid
anoth
activ
tmca
ester
isol
p
tenuifolia
possess
antidepressantlik
cognit
enhanc
cerebr
protect
effect
addit
prove
promot
viabil
rat
glioma
cell
bdnf
brain
deriv
neurotroph
factor
trkberk
extracellular
signalregul
kinas
signal
pathway
bioactivityguid
fraction
root
extract
p
tenuifolia
yield
constitu
solubl
epoxid
hydrolas
inhibitori
activ
tabl
includ
ester
thereinto
ester
display
potent
inhibit
solubl
epoxid
hydrolas
ic
half
maxim
inhibitori
concentr
valu
mm
ester
structur
similar
ester
perform
best
interact
solubl
epoxid
hydrolas
molecular
dock
rcsb
protein
data
bank
id
sar
research
result
demonstr
substitut
benzoic
acid
esterif
pyranos
help
compound
interact
activ
site
solubl
epoxid
hydrolas
zhao
et
al
present
one
major
metabolit
p
tenuifolia
rat
dosag
mm
markedli
shorten
action
potenti
durat
repolar
action
potenti
durat
repolar
cardiomyocyt
concentrationdepend
revers
manner
fig
moreov
ester
suppress
ltype
calcium
current
show
effect
neither
transient
outward
potassium
current
k
ss
steadyst
potassium
current
furthermor
abolish
isoprenalin
ead
earli
afterdepolar
suppress
dad
delayedafterdepolar
ta
trigger
activ
phenomenon
reveal
protect
heart
arrhythmia
via
inhibitori
effect
calcium
channel
ester
also
describ
probe
activ
site
esteras
name
faeiii
km
substrat
concentr
reaction
rate
half
v
max
valu
kcat
limit
rate
enzymecatalyz
reaction
satur
valu
pervillein
isol
character
erythroxylum
pervillei
fig
cholinerg
adrenerg
effect
investig
ester
mm
noncompetit
inhibit
cholinerg
respons
guineapig
ileum
affect
carbacholinduc
contract
rat
anococcygeu
smooth
muscl
research
indic
exhibit
weak
vascular
antiadrenerg
nonspecif
anticholinerg
effect
subsequ
compound
structur
similar
obtain
erythroxylum
pervillei
cytotox
isol
compon
mdr
multidrug
resist
inhibitor
specul
accord
sar
well
suggest
tmca
group
necessari
cytotox
rescinnamin
isol
rauvolfia
known
moderil
anaprel
consid
angiotensinconvert
enzym
inhibitor
use
antihypertens
drug
clinic
fig
ester
exhibit
signific
inhibit
sar
sever
acut
respiratori
syndrom
well
minim
concentr
inhibit
toward
sarscov
sar
coronaviru
approach
mm
analogu
reserpin
ester
bear
substitut
cinnam
place
substitut
benzoat
report
modul
mdr
ester
enhanc
cytotox
activ
natur
product
antitumor
drug
cemvlb
cell
differ
dosag
structurefunct
relationship
reveal
compound
retain
pendant
benzoyl
function
appropri
spatial
orient
modul
mdr
piplartin
also
known
piperlongumin
frequent
report
tmca
amid
isol
piper
plant
fig
piplartin
shown
effect
variou
ailment
includ
cancer
neurogen
diseas
arthriti
melanogenesi
lupu
nephriti
hyperlipidem
sever
relat
molecular
target
disclos
nfkb
nuclear
transcript
factorkb
mapk
mitogenactiv
protein
kinas
jak
janu
kinas
etc
structur
tmca
could
prepar
sever
kind
reaction
synthesi
cinnam
acid
includ
perkin
knoevenagel
reaction
synthesi
tmca
ester
amid
deriv
coupl
reaction
util
wide
catalyst
includ
dcc
dicyclohexylcarbodiimid
dmap
dmapedci
commonli
chosen
sometim
tmca
convert
cinnamoyl
chlorid
increas
activ
reaction
date
numer
tmca
ester
amid
analogu
synthes
evalu
bioacit
larg
unexplor
deriv
possess
varieti
pharmacolog
activ
rang
antitumor
antivir
cn
agnet
antimicrobi
antiinflammatori
hematolog
agent
next
deriv
discuss
one
one
follow
paragraph
nowaday
cancer
one
lead
caus
death
unremit
effort
made
research
develop
antitumor
agent
effici
safeti
far
variou
tmca
ester
amid
deriv
antitumor
effect
report
summar
progress
activ
compound
follow
antitumor
evalu
seri
oliv
secoiridoid
deriv
carri
busnena
cowork
tmca
introduc
give
esterif
product
tyrosol
e
major
oliv
phenol
oliv
oil
result
vitro
activ
demonstr
ester
fig
show
moder
antitumor
activ
human
breast
cancer
cell
ic
mm
cmet
tyrosineprotein
kinas
met
inhibit
possibl
mechan
sar
studi
indicatit
function
group
posit
hydrogen
bond
donor
bind
role
hydroxyl
group
conduc
inhibitori
activ
compar
group
aromat
ring
mdr
major
obstacl
success
cancer
chemotherapi
ester
inspir
lead
compound
quercetin
process
antitumor
activ
mdr
modul
activ
pgp
pglycoprotein
fig
mm
ester
show
high
pgp
bcrpmodul
activ
ester
use
along
evalu
cytotox
mention
cell
line
signific
cytotox
observ
ic
mm
accord
sar
investig
tmca
moieti
show
stronger
pgpmodul
bcrpmodul
activ
subtittu
benzoic
acid
ester
suggest
extra
bond
cinnam
acid
group
import
activ
ester
also
explor
mdr
modul
seri
analogu
synthes
split
cistran
isom
fig
among
ester
configur
transci
display
potent
mdr
modul
activ
valu
mm
ester
ester
deriv
methyl
epigallocatechin
possess
promis
pgp
inhibit
among
synthet
methyl
epigallocatechin
analogu
fig
noncytotox
ester
revers
drug
resist
pgptransfect
breast
cancer
cell
line
ec
nm
futher
studi
demonstr
ester
inhibit
activ
drug
efflux
pgp
transport
sar
investig
reveal
deriv
substitut
tmca
group
exhibit
favour
activ
cismethyl
epigallocatechin
deriv
transmethyl
gallocatechin
deriv
suggest
potenti
tmca
group
promit
activ
lead
compound
structur
tmca
ester
wide
use
modifi
natur
product
ester
structur
dihydroartemisinin
esterifi
tmca
exhibit
signific
antitumor
activ
fig
ic
valu
ester
cell
line
mm
respect
cytotox
ester
normal
hepat
cell
weak
ic
mm
meanwhil
si
select
index
ic
normal
cancer
valu
sar
one
hand
multimethoxyl
group
substitut
cinnam
acid
ester
perform
better
substitut
cinnam
acid
ester
hand
diester
deriv
exhibit
stronger
inhibitori
activ
compound
bare
hydroxi
dihydroartemisinin
gener
accord
pharmacolog
result
nam
et
al
execut
esterif
metabolit
plant
plant
crinum
latifolium
ester
show
moder
cytotox
cell
line
ic
valu
mgml
fig
promis
ester
substitut
deriv
structur
similar
ester
base
structur
precursor
dimethoxychalcon
seri
ester
deriv
synthes
among
ester
possess
broad
spectrum
antitumor
activ
differ
cell
line
fig
han
et
al
synthes
fumagillin
analogu
accord
molecular
model
human
methionin
among
ester
exhibit
strongest
antitumor
activ
cpae
cell
ic
valu
mgml
fig
respect
ester
interact
well
accord
dock
studi
subsequ
studi
ester
demonstr
inhibit
significantli
ic
valu
nm
sar
synthet
fumagillin
analogu
could
summar
aromat
ring
deriv
posit
contact
human
maxim
hydrophob
interact
activ
ciscinnam
acid
ester
deriv
much
less
transcinnam
acid
ester
deriv
structur
synthet
tmca
ester
deriv
antitumor
agent
piplartin
modifi
heterocycl
ring
via
baylishillman
reaction
deriv
determin
anticanc
activ
hela
cell
amid
demonstr
enforc
cell
cycl
inhibit
arrest
cell
phase
cell
cycl
fig
enhanc
mapk
activ
signific
potent
compound
use
along
combin
chemotherapeut
drug
combin
treatment
colcemid
hydroxyurea
enhanc
elong
inhibit
cell
adhes
cell
observ
multipl
piplartin
analogu
alkyl
halogen
substitu
morpholin
substitu
prepar
wu
et
al
compound
show
modest
select
human
fetal
lung
normal
cell
human
lung
normal
cell
among
synthet
compound
amid
fig
display
potent
inhibitori
four
cancer
cell
vitro
tabl
subsequ
amid
exert
signific
antitumor
potenc
ro
reactiv
oxygen
speci
elev
excel
sar
suggest
retain
vitro
anticanc
activ
analogu
morpholin
substitu
posit
piplartin
exhibit
diminish
cytotox
base
structur
piplartin
cenocladamid
seri
analogu
synthes
santo
et
al
amid
identifi
promis
compound
cell
ic
mm
fig
addit
amid
also
induc
apoptosi
sever
test
cell
line
efficaci
apoptosi
superior
posit
control
doxorubicin
prolifer
inhibit
also
show
select
amid
prove
unconspicu
cytotox
nontumorigen
cell
includ
ihmec
zeng
et
al
synthes
multipl
n
ndisubstitut
thiourea
analogu
inhibitor
heat
shock
protein
amid
fig
molecul
contain
tmca
amid
group
exhibit
favour
inhibit
fig
structur
synthet
tmca
amid
deriv
antitumor
agent
antitumor
activ
vitro
ic
ratio
mm
amid
potent
compound
percentag
inhibit
furthermor
amid
induc
mphase
arrest
cell
prove
substrat
pglycoprotein
drug
transport
seri
phenylcinnamid
synthes
assess
antitumor
activ
among
amid
show
moder
antitumor
effect
hela
cell
ic
valu
mm
fig
respect
potent
amid
posit
benzen
etherif
analogu
exert
apoptosi
effect
ic
valu
mm
mention
two
kind
cell
line
respect
accord
structur
combretastatin
precursor
exhibit
cytotox
effect
murin
lymphocyt
leukemia
seri
deriv
higher
aqueou
solubl
design
synthes
among
amid
fig
tmca
amid
show
favour
antitumor
activ
sever
kind
cell
line
tabl
potent
amid
structur
similar
sar
indic
benzen
cinnamid
help
promot
apoptosi
activ
inspir
structur
piplartin
suberoylanilid
hydroxam
acid
kind
hdaci
histon
deacetylas
inhibitor
activ
antileukem
amid
synthes
fig
amid
report
mediat
dna
damag
apoptosi
subsequ
amid
analogu
introduc
substitu
improv
apoptosi
activ
redcu
select
noncancer
cell
line
amid
also
perform
antileukem
activ
mediat
proapoptot
protein
express
inhibit
dna
repair
prosurviv
protein
express
interf
cellular
gsh
glutathion
defens
zhang
et
al
develop
namidin
scaffold
framework
mdr
modul
amid
analogu
two
unit
acryloyl
molecul
structur
prove
potenti
compound
among
deriv
fig
amid
mm
sensit
cell
toward
taxol
fold
ec
nm
potent
verapamil
tmca
amid
consid
bestatinbas
inhibitor
inhibitor
huvec
human
umbil
vein
endotheli
cell
seri
ahydroxybamino
amid
analogu
synthes
evalu
inhibit
huvec
growth
amid
fig
tmca
amid
analogu
exhibit
signific
inhibitori
effect
tabl
r
group
substitut
benzyl
group
huvec
growth
inhibit
favour
tmca
moieti
replac
group
inhibit
huvec
growth
ensur
time
varieti
viru
wide
exist
natur
threaten
public
health
tmca
use
design
antivir
agent
involv
antihbv
hepat
b
viru
antisar
antiinfluenza
agent
date
nearli
report
effect
antivir
analogu
tmca
ester
sixteen
phenylpropion
acid
analogu
prepar
screen
antihbv
effect
ester
fig
research
group
jijun
chen
synthes
numer
naturalbas
compound
measur
antihbv
activ
sever
tmca
ester
exhibit
antihbv
activ
studi
tabl
caudatin
effect
antihbv
precursor
tetracycl
triterpenoid
separ
cynanchum
bunge
modifi
cinnam
acid
measur
antihbv
activ
ester
fig
ester
fig
esterifi
deriv
andrographolid
also
perform
moder
antihbv
effect
cc
valu
mm
cell
ic
valu
hbsag
hbeag
mm
respect
ic
valu
inhibit
hbv
dna
replic
mm
tmca
consid
one
group
favour
enhanc
antihbv
activ
accord
sar
phydroxyacetophenon
isol
artemisia
capillari
explor
precursor
antihbv
agent
seri
anlogu
synthes
identif
mitsunobu
reaction
primari
hydroxyl
group
pyranos
among
synthet
compound
ester
fig
sar
conclud
glycosid
show
stronger
inhibitori
activ
aglycon
gener
meanwhil
cinnam
acid
analogu
posit
methoxyl
fluoro
group
exhibit
potenti
activ
substitut
analogu
accord
structur
effect
ester
tetrapeptid
aldehyd
sar
seri
deriv
synthes
ester
fig
show
weak
antisar
cov
mutant
proteas
effect
ic
mm
interestingli
accord
anoth
research
result
author
tmca
amid
analogu
report
promis
compound
among
design
deriv
author
consid
planar
aromat
ring
hydrophob
function
structur
substitut
group
essenti
inhibitori
activ
inspir
structur
pentaogalloylbdglucos
sever
deriv
synthes
determin
antiinfluenza
activ
compar
benzoic
acid
substitut
deriv
ester
show
stronger
inhibit
influenza
ester
fig
compos
dmannos
five
unit
tmca
show
potent
antiinfluenza
effect
configur
ester
mixtur
aand
banom
ratio
ab
cn
disord
made
multipl
diseas
whose
symptom
contain
cognit
impair
maniac
depress
behavior
affect
million
peopl
around
world
complex
pathogenesi
develop
cn
agent
high
invest
low
return
coher
bioactiv
precursor
tmca
tmca
ester
amid
analogu
report
show
cn
activ
includ
antinarcot
neuroprotect
antialzheim
anticonvuls
effect
sever
target
involv
ach
acetylcholin
buch
butyrocholinesteras
ab
nuclear
factor
seri
tmca
analog
synthes
examin
antinarcot
activ
ester
deriv
synthes
acyl
chlorin
tmca
among
ester
fig
exhibit
moder
antinarcot
vivo
vitro
dose
kgmg
suppress
naloxonestimul
jump
behavior
morphinedepend
mice
moreov
inhibit
ic
valu
mm
accord
structur
sintenin
lignanoid
isol
piper
sintenens
jung
et
al
synthes
multipl
ester
analogu
neuroprotect
effect
synthet
ester
determin
vitro
model
ester
fig
show
moder
neuroprotect
activ
dpph
hydrazyl
radic
scaveng
model
inhibit
mgml
higher
posit
control
quercetin
studi
reveal
caffeic
acid
substitut
ester
show
potent
neuroprotect
effect
suppress
h
induc
oxid
injuri
cell
ester
fig
esterifi
deriv
activ
lead
compoundtacrin
confirm
show
potenti
investig
suggest
electronwithdraw
substitu
benzen
ring
cinnam
conduct
improv
inhibitori
activ
ach
buch
ab
aggreg
jung
et
al
synthes
sever
tmca
amid
measur
antinarcot
activ
reaction
detail
prepar
tmca
describ
among
homolog
amid
fig
potenti
amid
vivo
vitro
dose
mgkg
ip
significantli
decreas
naloxoneinduc
jump
behavior
morphinedepend
mice
inhibit
ratio
valu
respect
vitro
exhibit
favour
bind
affin
serotonerg
receptor
transport
tabl
amid
display
signific
bind
affin
receptor
addit
possess
differ
bind
affin
mention
receptor
abil
activ
perk
express
amid
also
determin
result
indic
amid
moder
increas
express
perk
amid
fig
report
effect
inhibit
seizureinduc
mediat
neuron
injuri
prostaglandin
receptor
subtyp
potent
molecular
synthet
analogu
possess
competit
antagon
receptor
k
b
nm
meanwhil
prostaglandin
receptor
receptor
k
b
valu
mm
si
furhermor
brainperm
agent
inhibt
upregul
prostaglandinendoperoxid
synthas
mrna
rat
cultur
microglia
activ
markedli
decreas
neuron
injuri
hippocampu
administ
mice
begin
h
termin
pilocarpineinduc
statu
epilepticu
result
reveal
effect
treat
inflammationrel
brain
injuri
base
structur
amid
synthes
evalu
select
prostanoid
receptor
seri
piplartin
analogu
synthes
measur
cytoprotect
hydrogen
peroxideand
neuron
cell
oxid
damag
cell
amid
fig
show
low
cytotox
confer
potent
protect
cell
oxid
injuri
via
upregul
panel
cellular
antioxid
molecul
genet
silenc
transcript
factor
master
regul
cellular
stress
respons
suppress
cytoprotect
indic
critic
involv
cellular
action
cell
cinepazid
fig
market
drug
use
treatment
cardiovascular
cerebrovascular
diseas
peripher
vascular
diseas
cinepazid
also
regard
tmca
amid
analogu
amid
suggest
protect
neuron
cell
affect
mitochondri
function
detail
inhibit
ogd
oxygeneglucos
depriv
induc
oxid
stress
support
capabl
reduc
intracellular
reactiv
oxygen
speci
malondialdehyd
product
enhanc
superoxid
dismutas
activ
furthermor
found
sustain
function
mitochondri
function
via
stabil
mitochondri
membran
potenti
promot
ogdinduc
suppress
mitochondri
respiratori
complex
activ
enhanc
atp
adenosinetriphosph
product
jung
cowork
present
simpl
synthesi
tmca
amid
evalu
bioactiv
synthes
amid
determin
radic
scaveng
activ
neurotox
inhibit
antinarcot
activ
signific
radic
scaveng
activ
observ
test
amid
compar
refer
materi
vitro
amid
fig
show
potent
neuroprotect
activ
glutamateinduc
primari
cortic
neuron
cell
dose
rang
mm
meanwhil
analogu
show
antinarcot
properti
vivo
amid
display
strongest
inhibit
among
exam
amid
indic
tmca
moieti
essenti
enhanc
antinarcot
activti
tmca
ester
ester
amid
analogu
appli
synthes
antimicrobi
agent
well
activ
deriv
report
suppress
growth
strain
includ
ustilaginoidea
oryza
pyricularia
oryza
p
falciparum
aureu
c
krusei
trypanosoma
cruzi
trichodermin
cinnam
acid
ester
deriv
prepar
zheng
et
al
among
obtain
compound
ester
fig
exhibit
moder
inhibit
ustilaginoidea
oryza
pyricularia
oryza
vitro
ec
valu
mm
respect
ester
deriv
substitut
orthofluorin
cinnam
acid
exhibit
prodomin
inhibit
mention
strain
ec
valu
mm
respect
effect
even
better
market
drug
prochloraz
could
relat
function
fluorin
moieti
inhibit
microbi
sever
studi
report
ester
includ
tmca
moieti
possess
antimalari
effect
indic
tmca
could
import
group
develop
antimalari
agent
analogu
neolignan
ester
fig
identifi
measur
antimalari
activ
vitro
result
reveal
exhibit
moder
antimalari
activ
blood
form
chloroquineresist
p
falciparum
ic
valu
hhypoxantin
hrpii
mm
anticip
power
antimalari
activ
aratikatla
et
al
exploit
seri
syncarpamid
analogu
investig
efficaci
vivo
vitro
among
synthet
compound
ester
fig
display
strongest
inhibit
strain
p
falciparum
ic
valu
mm
respect
unfortun
signific
effect
inhibit
strain
plasmodium
vivo
dai
et
al
modifi
structur
kniphofion
b
two
lead
compound
separ
kniphofia
ensifolia
ester
fig
report
show
mark
antiplasmodi
effect
chloroquineresist
strain
p
falciparum
ic
mm
potent
ester
structur
similar
ic
valu
mm
ester
exert
time
effici
kniphofion
b
fregnan
et
al
synthes
sever
analogu
piplartin
evalu
antimicrobi
activ
analogu
amid
fig
potent
amid
tabl
amid
display
threefold
potent
piplartin
antibacteri
evalu
aureu
fivefold
less
toxic
piplartin
amid
possess
fourfold
potent
antifung
evalu
c
krusei
fivefold
less
toxic
piplartin
sar
possibl
note
aromat
ring
lack
methoxyl
moieti
import
antibacteri
activ
compound
hand
trimethoxyphenyl
group
substitut
benzen
ring
imper
antifung
activ
carvalho
et
al
synthes
sever
cinnam
nacylhydrazon
measur
antitrypanosom
effect
amid
fig
deriv
transbarylacrylamido
carbamoyl
azithromycin
synthes
assess
antibacteri
effect
nine
signific
pathogen
amid
fig
exhibit
moder
antibacteri
effect
suscept
resist
strain
tabl
potent
amid
structur
close
reveal
substitut
moieti
enhanc
antibacteri
activ
lead
compound
inflamm
bodi
natur
respons
extern
infect
tmca
ester
amid
deriv
report
show
antiinflammatori
activ
target
includ
tnfa
tumor
necrosi
factor
nitric
oxid
nfkb
ku
et
al
combin
carbazol
cinnamoyl
group
measur
vascular
barrier
protect
effect
deriv
fig
structur
synthet
tmca
amid
deriv
antimicrobi
agent
ester
fig
exhibit
mark
inhibit
high
mobil
group
protein
mediat
hyperperm
dose
mm
inhibit
hyperperm
remark
inhibit
elisa
od
valu
mice
model
also
suppress
hyperperm
inhibit
result
demonstr
could
potent
agent
inhibit
inflammatori
respons
kumar
et
al
report
ester
fig
isol
piper
longum
inhibit
eselectin
induct
tnfa
one
thionocinnam
homolog
exhibit
better
inhibit
concentr
mgml
exert
inhibit
express
ic
mgml
consequ
abolish
adhes
neutrophil
endotheli
monolay
induct
tnfa
sar
investig
indic
critic
role
chainlength
alkyl
moieti
alcohol
moieti
number
methoxi
group
aromat
ring
cinnamoyl
moieti
presenc
bcc
doubl
bond
thiocinnam
thionocinnam
seri
analogu
piplartin
synthes
investig
antiinflammatori
activ
among
amid
fig
exhibit
better
inhibit
dose
mm
lp
lipopolysaccharid
induc
product
inhibit
four
mention
amid
inhibit
respect
addit
cytotox
four
amid
macrophag
measur
ic
valu
mm
respect
sun
et
al
design
synthes
sever
piplartin
deriv
analogu
fig
keton
analogu
amid
group
replac
carbonyl
increas
electrophil
certifi
show
potenti
lead
amid
piplartin
block
lpsinduc
secret
well
ino
induct
nitric
oxid
synthas
express
macrophag
tmca
amid
reveal
show
hematolog
activ
antiaggregatori
haemostat
effect
rel
effectssubstitut
cinnamoyltyramin
analogu
synthes
evalu
platelet
antiaggregatori
activ
among
synthet
deriv
amid
fig
exhibit
moder
platelet
antiaggregatori
activ
dosag
mgml
amid
suppress
paf
plateletactiv
factor
receptor
bind
rabbit
platelet
inhibit
respect
tabl
concentr
mg
ml
inhibit
paf
induc
platelet
aggreg
investig
aggreg
inhibit
piplartin
analogu
seir
deriv
piplartin
synthes
park
et
al
among
deriv
amid
fig
display
promis
platelet
aggreg
inhibitori
effect
differ
model
tabl
sar
research
reveal
ad
methyl
group
posit
piperidin
ring
exert
mix
effect
promot
inhibitori
effect
thrombin
collageninduc
platelet
aggreg
reduc
inhibit
arachidon
acidinduc
platelet
aggreg
ten
new
cinnamamid
deriv
contain
substructur
present
potent
haemostat
agent
among
studi
seri
amid
fig
exhibit
coagul
activ
certain
extent
amid
promot
platelet
aggreg
ic
mmoll
potent
etamsyl
amid
show
lowest
tt
thrombin
time
valu
among
analogu
moreov
improv
platelet
aggreg
rel
etamsyl
promot
aptt
activ
partial
thromboplastin
time
pt
prothrombin
time
suggest
show
haemostat
activ
stimul
fibrinogen
promot
fibrin
activ
platelet
aggreg
apart
bioactiv
describ
tmca
amid
deriv
exhibit
acat
oacyltransferas
aldos
reductas
inhibitori
well
seri
yakuchinon
b
deriv
synthes
assess
lipidlow
activ
promis
amid
vivo
amid
fig
inhibit
rat
hepat
cholesterol
acat
signific
posit
control
exert
remark
hypocholesterolem
activ
subsequ
research
implic
male
rat
could
better
metabol
femal
sexrel
differ
express
toxicolog
research
relev
decreas
accumul
metabol
femal
rat
piplartin
prove
suppress
recombin
human
ic
mm
improv
activ
multipl
deriv
prepar
modif
styrylaromat
heterocycl
ring
function
fig
esterif
amid
still
play
signific
role
discov
develop
new
drug
amid
bond
format
domin
frequent
use
reaction
give
product
even
though
new
synthet
reaction
spring
compar
modif
esterif
amid
easi
exert
metabol
characterist
lead
compound
moreov
esterif
amid
easili
control
industri
scale
product
target
compound
current
difficulti
develop
new
drug
discov
novel
lead
compound
instead
synthsi
promis
precursor
tmca
clearli
evid
tmca
ester
amid
analogu
possess
diversifi
biolog
activ
immens
potenti
field
medicin
chemistri
discuss
review
articl
focus
pharmacolog
activ
natur
synthet
tmca
ester
amid
deriv
variou
therapeut
target
report
recent
present
survey
indic
tmca
ester
amid
deriv
target
antitumor
antivir
cn
agnet
antimicrobi
antiinflammatori
hematolog
agent
much
scope
potent
tmca
ester
amid
moieti
therapeut
target
futur
investig
scaffold
could
give
encourag
result
field
medicin
chemistri
neglect
ester
gener
perform
poor
pharmacokinet
limit
druggabl
still
gap
wait
overcom
tmca
deriv
develop
market
drug
anticip
inform
compil
review
articl
updat
research
recent
report
biolog
activ
tmca
ester
amid
analogu
deriv
also
motiv
design
synthes
promis
tmca
ester
amid
improv
medicin
properti
none
author
conflict
interest
disclos
